Special Libraries, February 1978

Volume 69, Issue 2https://scholarworks.sjsu.edu/sla_sl_1978/1001/thumbnail.jp

Special Libraries, December 1961

Volume 52, Issue 10https://scholarworks.sjsu.edu/sla_sl_1961/1009/thumbnail.jp

Register of specialized sources for information on selected fuels and oxidizers

Thirty-eight (38) organizations are listed and described that catalog and file information in their data systems on fuel and oxidizers. The fuels include hydrogen, methane and hydrazine-type fuels; the oxidizers include oxygen, fluorine, flox, nitrogen tetroxide and ozone. The type of available information covers thermophysical properties, propellant systems, propellant fires-control-extinguishment, propellant explosions, propellant combustion, propellant safety, and fluorine chemistry. These organizations have assembled and collated their information so that it will be useful in the solution of engineering problems

The emergence of new technologies in the ICT field: main actors, geographical distribution and knowledge sources

This paper examines the emergence of technologies, applications and platforms in the area of information and communication technologies (ITC), using patent data. It detects new technologies/applications/products using patents' abstracts and describes them looking at their degree of "hybridisation", in terms of technological domains and knowledge base, at the role of firms in driving the innovation activity, and at the geographical distribution of the innovation. The results show that in emerging technologies in ITC are more concentrated across technological classes and across firms than non emerging ones, and that this pattern is invariant across major countries. Furthermore, a preliminary analysis on patent citations show that in emerging technologies knowledge sources are more specific in terms of technological classes and more dispersed in terms of cited institutions. Also there is evidence of a role for universities and public research centres as sources of knowledge

Preliminary Report on Patent Literature, Search Methodology and Patent Status of Medicines on the WHO EML 2009

Over the past several decades the World Health Organization (WHO) has produced the Essential Medicines List (EML) to assist countries in deciding what medicines should be essential and available in National Essential Medicine Lists.1 WHO, through the work of regional offices, supports nations using the EML to ensure the quality, availability, and affordability of pharmaceuticals required to promote and advance public health in nations across the globe. However in some cases, access to EML pharmaceuticals might be complicated by existing patents, i.e., where issued, patent rights might pose obstacles to access and inclusion in national EMLs. Indeed, in developed and emerging economy national jurisdictions patent protection may be in effect for a not insignificant number of the WHO EML pharmaceuticals (Figure 2A). However, in developing countries, it is uncertain whether these patents have been filed or issued. Without patent data predicated on an established, reproducible protocol for accessing and assembling patent information on the EML pharmaceuticals, discussions, debates and strategic approaches to understanding and managing patents with regard to access and delivery to developing countries remain in the dark. Indeed, it is absurd to make policy and formulate strategy without solid patent information: the critical foundation for rational debate. To analyze the degree and scope of patenting of EML pharmaceuticals, WIPO (with WHO) approached the Franklin Pierce Center for Intellectual Property at the University of New Hampshire School of Law, specifically the International Technology Transfer Institute (ITTI) to generate a preliminary overview of patents appurtenant to recently added pharmaceutical updates to the EML.2 As part of this work, with inputs from WHO and WIPO, ITTI developed novel methodology and a detailed protocol for identifying EML pharmaceutical patents in national jurisdictions, with an easily reproducible yet cost effective template. Herein is described the development of such a protocol and a preliminary pool of patent information that illustrates its utility. The protocol yields data in a layered approach thereby allowing a user to quickly and effectively obtain both broad and detailed patent information for medications on the WHO EML. In addition, the protocol can be used as an initial path for targeted strategic analysis of potentially relevant patent information in national jurisdictions. In sum, the objectives for this project were: To develop a robust methodology to assess the patent status of medicines on the WHO Model List of Essential Medicines; To place in the public domain a detailed report on the present (2010) patent status of medicines that were on patent in 2003 and those medicines added to the Model List since 2003 by country and level of development; and To analyze the patent status of these Essential Medicines by the development status of countries. The report describes the development of the protocol and presents a preliminary list of EML and corresponding patents in certain jurisdictions to illustrate the utility of the approach. Results will be discussed both in terms of global access and patents, and in the context of establishing standard, systematic, protocols for periodic patent searches related to EML content. 1 WORLD HEALTH ORGANIZATION, CONTINUITY AND CHANGE IMPLEMENTING THE THIRD WHO MEDICINES STRATEGY 2008--‐2013 20 (WHO Press, 3rd ed. 2009). 2 This report covers the EML up to and including updates until 2009

Special Libraries, September 1946

Volume 37, Issue 7https://scholarworks.sjsu.edu/sla_sl_1946/1006/thumbnail.jp

Special Libraries, December 1974

Volume 65, Issue 12https://scholarworks.sjsu.edu/sla_sl_1974/1008/thumbnail.jp

Bibliometric Perspectives on Medical Innovation using the Medical Subject Headings (MeSH) of PubMed

Multiple perspectives on the nonlinear processes of medical innovations can be distinguished and combined using the Medical Subject Headings (MeSH) of the Medline database. Focusing on three main branches-"diseases," "drugs and chemicals," and "techniques and equipment"-we use base maps and overlay techniques to investigate the translations and interactions and thus to gain a bibliometric perspective on the dynamics of medical innovations. To this end, we first analyze the Medline database, the MeSH index tree, and the various options for a static mapping from different perspectives and at different levels of aggregation. Following a specific innovation (RNA interference) over time, the notion of a trajectory which leaves a signature in the database is elaborated. Can the detailed index terms describing the dynamics of research be used to predict the diffusion dynamics of research results? Possibilities are specified for further integration between the Medline database, on the one hand, and the Science Citation Index and Scopus (containing citation information), on the other.Comment: forthcoming in the Journal of the American Society for Information Science and Technolog

Special Libraries, December 1959

Volume 50, Issue 10https://scholarworks.sjsu.edu/sla_sl_1959/1009/thumbnail.jp

A regional technology transfer program

The final report is presented for the North Carolina Science and Technology Research Center's 14th consecutive contract period as a NASA Industrial Applications Center, serving the information needs of nine Southeastern states. Included in the report are figures for and analysis of marketing efforts, file usage, search delivered, and other services performed for clients; and information on staff changes, workshops, and special projects in 1978. An appendix contains copies of NC/STRC magazine advertisements, letters from clients, and supplementary information on NC/STRC staff and services